Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Adverum Biotechnologies Inc (NQ: ADVM )

6.630 +0.040 (+0.61%)
Streaming Delayed Price Updated: 1:15 PM EDT, Oct 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Adverum Biotechnologies Inc

10 Biotech Stocks Below Cash Value with Key Catalysts on the Horizon: An Analysis
Via ACCESSWIRE
The Sonic Fund II, L.P. Comments on Preliminary Voting Results of Adverum Annual Meeting
From The Sonic Fund II, L.P.
Via Business Wire
The Sonic Fund II, L.P. Issues Statement to Adverum Stockholders
From The Sonic Fund II, L.P.
Via Business Wire
The Sonic Fund II, L.P. Reminds Adverum Stockholders to Vote for Its Three Independent Director Nominees at May 12 Annual Meeting
From The Sonic Fund II, L.P.
Via Business Wire
Glass Lewis Joins ISS In Recommending Adverum Shareholders Vote for All Three Independent Sonic Director Nominees
From The Sonic Fund II, L.P.
Via Business Wire
ISS Recommends Adverum Stockholders Vote to Elect Sonic’s Three Independent, Highly Qualified Nominees
From The Sonic Fund II, L.P.
Via Business Wire
The Sonic Fund II, L.P. Comments on Adverum Biotechnologies Update Regarding INFINITY Phase 2 Trial of ADVM-022
From The Sonic Fund II, L.P.
Via Business Wire
The Sonic Fund II, L.P. Issues Presentation Correcting Adverum’s Misstatements
From The Sonic Fund II, L.P.
Via Business Wire
The Sonic Fund II, L.P. Issues Presentation Detailing Compelling Case for Immediate Board Upgrade at Adverum Biotechnologies, Inc.
From The Sonic Fund II, L.P.
Via Business Wire
The Sonic Fund II, L.P. Files Definitive Proxy Statement and Sends Letter to Stockholders of Adverum Biotechnologies, Inc.
From The Sonic Fund II, L.P.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.